Bharat Immunologicals Return On Asset

BIBCL -- India Stock  

INR 20.40  1.55  8.22%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Symbol
Refresh

Return On Asset Analysis

Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Bharat Immunologicals 
Return on Asset 
 = 
Net Income 
Total Assets 
X
100 
 = 
(1.69) %

About Return On Asset

Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Compare to competition
Based on latest financial disclosure Bharat Immunologicals Biologicals Corp Ltd has Return On Asset of -1.69%. This is much lower than that of the Healthcare sector, and significantly lower than that of Return On Asset industry, The Return On Asset for all stocks is over 1000% higher than the company.

Peer Comparison

Bharat Immunologicals Return On Asset Comparison
Bharat Immunologicals is currently under evaluation in return on asset category among related companies.

Did you try this?

Run Fund Screener Now
   

Fund Screener

Find activelly-traded funds from around the world traded on over 30 global exchanges
All  Next Launch Fund Screener

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Fundamental Indicators

Current Bharat Immunologicals financial ratios